Isolation of vaginal lactobacilli and characterization of anti-candida activity

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Parolin, Carola ^a   Marangoni, Antonella ^a   Laghi, Luca ^a   Foschi, Claudio ^a   Palomino, Rogers Alberto Ñahui ^a   Calonghi, Natalia ^a   Cevenini, Roberto ^a   Vitali, Beatrice ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; HISTONE DEACETYLASE; HYDROGEN PEROXIDE; LACTIC ACID; PROBIOTIC AGENT; RNA 16S; ANTIFUNGAL AGENT;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CELL ADHESION; CLAVISPORA LUSITANIAE; CONTROLLED STUDY; DILUTION; ENZYME INHIBITION; FEMALE; FUNGICIDAL ACTIVITY; FUNGUS ISOLATION; GENE SEQUENCE; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS GASSERI; LACTOBACILLUS VAGINALIS; METABOLOME; NONHUMAN; NUCLEOTIDE SEQUENCE; PICHIA KUDRIAVZEVII; PREMENOPAUSE; PROTON NUCLEAR MAGNETIC RESONANCE; SUPERNATANT; TAXONOMY; ADOLESCENT; CANDIDA; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; METABOLOMICS; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; VAGINA; VAGINA CANDIDIASIS; YOUNG ADULT;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS GASSERI; LACTOBACILLUS VAGINALIS;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; BASE SEQUENCE; CANDIDA; CANDIDIASIS, VULVOVAGINAL; FEMALE; HELA CELLS; HUMANS; HYDROGEN PEROXIDE; LACTOBACILLUS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOMICS; MICROBIOTA; MIDDLE AGED; MOLECULAR SEQUENCE DATA; VAGINA; YOUNG ADULT;

EID: 84939241322     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131220     Document Type: Article

References (50)

1. Sobel JD. Vaginitis. N Engl J Med. 1997; 337:1896-1903. PMID:9407158
2. Larsen B, Monif GR. Understanding the bacterial flora of the female genital tract. Clin Infect Dis. 2001; 32:e69-77. PMID:11181139
3. Hyman RW, Fukushima M, Diamond L, Kumm J, Giudice LC, Davis RW. Microbes on the human vaginal epithelium. Proc Natl Acad Sci USA. 2005; 102:7952-7957. PMID:15911771
4. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive- age women. Proc Natl Acad Sci USA. 2011; 108 Suppl 1:4680-4687. doi:10.1073/pnas. 1002611107 PMID:20534435
5. Aroutcheva A, Gariti D, Simon M, Shott S, Faro J, Simoes JA, et al. Defense factors of vaginal lactobacilli. Am J Obstet Gynecol. 2001; 185:375-379. PMID:11518895
6. Kaewsrichan J, Peeyananjarassri K, Kongprasertkit J. Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens. FEMS Immunol Med Microbiol. 2006; 48:75-83. PMID:16965354
7. Reid G, Younes JA, Van der Mei HC, Gloor GB, Knight R, Busscher HJ. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol. 2011; 9:27-38. doi:10.1038/nrmicro2473 PMID:21113182
8. Borges S, Silva J, Teixeira P. The role of lactobacilli and probiotics in maintaining vaginal health. Arch Gynecol Obstet. 2014; 289:479-489. doi:10.1007/s00404-013-3064-9 PMID:24170161
9. Reid G, Beuerman D, Heinemann C, Bruce AW. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunol Med Microbiol. 2001; 32:37-41. PMID:11750220
10. Burton JP, Cadieux PA, Reid G. Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol. 2003; 69:97-101. PMID:12513982
11. Donders GG, Van Bulck B, Van de Walle P, Kaiser RR, Pohlig G, Gonser S, et al. Effect of lyophilized lactobacilli and 0.03 mg estriol (Gynoflor) on vaginitis and vaginosis with disrupted vaginal microflora: a multicenter, randomized, single-blind, active-controlled pilot study. Gynecol Obstet Invest. 2010; 70:264-272. doi:10.1159/000314016 PMID:21051846
12. Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010; 59(RR-12):1-110. PMID:21160459
13. Rathod SD, Buffler PA. Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented. BMC Women's Health. 2014; 14:43.
14. Cotch MF, Hillier SL, Gibbs RS, Eschenbach DA. Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol. 1998; 178:374-380. PMID:9500502
15. Babula O, Lazdane G, Kroica J, Linhares IM, Ledger WJ, Witkin SS. Frequency of interleukin-4 (IL-4) gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis. Clin Infect Dis. 2005; 40:1258-1262. PMID:15825027
16. Sobel JD. Vulvovaginal candidosis. Lancet. 2007; 369:1961-1971. PMID:17560449
17. Coste A, Selmecki A, Forche A, Diogo D, Bougnoux ME, d'Enfert C, et al. Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates. Eukaryot Cell. 2007; 6:1889-1904. PMID:17693596
18. Falagas ME, Betsi GI, Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J Antimicrob Chemother. 2006; 58:266-272. PMID:16790461
19. Köhler GA, Assefa S, Reid G. Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans. Infect Dis Obstet Gynecol. 2012; 2012:636474. doi:10.1155/2012/636474 PMID:22811591
20. Vitali B, Pugliese C, Biagi E, Candela M, Turroni S, Bellen G, et al. Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCRdenaturing gradient gel electrophoresis and real-time PCR. Appl Environ Microbiol. 2007; 73: 5731-5741. PMID:17644631
21. Osset J, Bartolomé RM, García E, Andreu A. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis. 2001; 183:485-491. PMID:11133381
22. Rizzo A, Losacco A, Carratelli CR. Lactobacillus crispatus modulates epithelial cell defense against Candida albicans through Toll-like receptors 2 and 4, interleukin 8 and human β-defensins 2 and 3. Immunol Lett. 2013; 156:102-109. doi:10.1016/j.imlet.2013.08.013 PMID:24120511
23. Donnarumma G, Molinaro A, Cimini D, De Castro C, Valli V, De Gregorio V, et al. Lactobacillus crispatus L1: high cell density cultivation and exopolysaccharide structure characterization to highlight potentially beneficial effects against vaginal pathogens. BMC Microbiol. 2014; 14:137.
24. Verdenelli MC, Coman MM, Cecchini C, Silvi S, Orpianesi C, Cresci A. Evaluation of antipathogenic activity and adherence properties of human Lactobacillus strains for vaginal formulations. J Appl Microbiol. 2014; 116:1297-1307. doi:10.1111/jam.12459 PMID:24552173
25. Simonetti G, Passariello C, Rotili D, Mai A, Garaci E, Palamara AT. Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans. FEMS Yeast Res. 2007; 7:1371-1380. PMID:17627775
26. Hnisz D, Majer O, Frohner IE, Komnenovic V, Kuchler K. The Set3/Hos2 histone deacetylase complex attenuates cAMP/PKA signaling to regulate morphogenesis and virulence of Candida albicans. PLoS Pathog. 2010; 6:e1000889. doi:10.1371/journal.ppat.1000889 PMID:20485517
27. Wurtele H, Tsao S, Lépine G, Mullick A, Tremblay J, Drogaris P, et al. Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy. Nat Med. 2010; 16:774-780. doi:10.1038/nm. 2175 PMID:20601951
28. Smith WL, Edlind TD. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation. Antimicrob Agents Chemother. 2002; 46:3532-3539. PMID:12384361
29. Nguyen LN, Lopes LC, Cordero RJ, Nosanchuk JD. Sodium butyrate inhibits pathogenic yeast growth and enhances the functions of macrophages. J Antimicrob Chemother. 2011; 66:2573-2580. doi:10. 1093/jac/dkr358 PMID:21911344
30. Latham T, Mackay L, Sproul D, Karim M, Culley J, Harrison DJ, et al. Lactate, a product of glycolytic metabolism, inhibits histone deacetylase activity and promotes changes in gene expression. Nucleic Acids Res. 2012; 40:4794-4803. doi:10.1093/nar/gks066 PMID:22323521
31. Laghi L, Picone G, Cruciani F, Brigidi P, Calanni F, Donders G, et al. Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis. Antimicrob Agents Chemother. 2014; 58:3411-3420. doi:10.1128/AAC.02469-14 PMID:24709255
32. Walter J, Hertel C, Tannock GW, Lis CM, Munro K, Hammes WP. Detection of Lactobacillus, Pediococcus, Leuconostoc, and Weissella species in human feces by using group-specific PCR primers and denaturing gradient gel electrophoresis. Appl Environ Microbiol. 2001; 67:2578-2585. PMID:11375166
33. Lane DJ. 16S/23S rRNA sequencing. In: Stackebrandt E, Goodfellow M, eds. Nucleic Acid Techniques in Bacterial Systematics. New York: Wiley. 1991; 115-175.
34. Cole JR, Wang Q, Cardenas E, Fish J, Chai B, Farris RJ, et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 2009; 37:D141-145. doi:10.1093/nar/gkn879 PMID:19004872
35. Pendharkar S, Magopane T, Larsson PG, de Bruyn G, Gray GE, Hammarström L, et al. Identification and characterisation of vaginal lactobacilli from South African women. BMC Infect Dis. 2013; 13:43. doi:10.1186/1471-2334-13-43 PMID:23351177
36. Giraudeau P, Silvestre V, Akoka S. Optimizing water suppression for quantitative NMR-based metabolomics: a tutorial review. Metabolomics. 2015; doi:10.1007/s11306-015-0794-7 PMID:25983674
37. EUCAST definitive document E.DEF 9.2 [internet]. Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agent for yeast. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility testing (EUCAST) [updated 2014 Jul 7; cited 2014 Dec 1]. Available: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/AFST/Files/EUCAST-AFST-EDEF-9-2-Mould-testing-20140815.pdf.
38. Liu W, Li LP, Zhang JD, Li Q, Shen H, Chen SM, et al. Synergistic antifungal effect of glabridin and fluconazole. PLoS One. 2014; 9:e103442. doi:10.1371/journal.pone.0103442 PMID:25058485
39. Mastromarino P, Brigidi P, Macchia S, Maggi L, Pirovano F, Trinchieri V, et al. Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. J Appl Microbiol. 2002; 93:884-893. PMID:12392537
40. Knapp AR, Ren C, Su X, Lucas DM, Byrd JC, Freitas MA, et al. Quantitative profiling of histone posttranslational modifications by stable isotope labeling. Methods. 2007; 41:312-319. PMID:17309842
41. De Seta F, Parazzini F, De Leo R, Banco R, Maso GP, De Santo D, et al. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study. Eur J Obstet Gynecol Reprod Biol. 2014; 182:136-139. doi:10.1016/j.ejogrb.2014.09.018 PMID:25305660
42. Antonio MA, Hawes SE, Hillier SL. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis. 1999; 180:1950-1956. PMID:10558952
43. Verstraelen H, Verhelst R, Claeys G, De Backer E, Temmerman M, Vaneechoutte M. Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal microflora and that L. gasseri and/or L. iners are more conducive to the occurrence of abnormal vaginal microflora. BMC Microbiol. 2009; 9:116. doi:10.1186/1471-2180-9-116 PMID:19490622
44. Van de Wijgert JH, Borgdorff H, Verhelst R, Crucitti T, Francis S, Verstraelen H, et al. The vaginal microbiota: what have we learned after a decade of molecular characterization?. PLoS One. 2014; 9(8):e105998. doi:10.1371/journal.pone.0105998 PMID:25148517
45. Falsen E, Pascual C, Sjödén B, Ohlén M, Collins MD. Phenotypic and phylogenetic characterization of a novel Lactobacillus species from human sources: description of Lactobacillus iners sp. nov. Int J Syst Bacteriol. 1999; 49:217-221. PMID:10028266
46. Macklaim JM, Fernandes AD, Di Bella JM, Hammond JA, Reid G, Gloor GB. Comparative meta-RNAseq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome. 2013; 1:12. doi:10.1186/2049-2618-1-12 PMID:24450540
47. Köhler GA, Assefa S, Reid G. Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans. Infect Dis Obstet Gynecol. 2012; PMID:636474.
48. Abramov V, Khlebnikov V, Kosarev I, Bairamova G, Vasilenko R, Suzina N, et al. Probiotic Properties of Lactobacillus crispatus 2,029: Homeostatic Interaction with Cervicovaginal Epithelial Cells and Antagonistic Activity to Genitourinary Pathogens. Probiotics Antimicrob Proteins. 2014; 6:165-176. doi:10.1007/s12602-014-9164-4 PMID:25028263
49. Bisanz JE, Seney S, McMillan A, Vongsa R, Koenig D, Wong L, et al. A systems biology approach investigating the effect of probiotics on the vaginal microbiome and host responses in a double blind, placebo-controlled clinical trial of post-menopausal women. PLoS One. 2014; 9:e104511. doi:10. 1371/journal.pone.0104511 PMID:25127240
50. FAO/WHO. Probiotics in food. Health and nutritional properties and guidelines for evaluation. FAO Food and Nutritional paper No. 85. 2006 (ISBN 92-5-105513-0).